Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jeffrey Larson

1PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 10, 2025
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.

Apostolia M Tsimberidou, David J Vining, Sukeshi P Arora

Pageof 1

Frequent Collaborators

1 joint publications

Apostolia M Tsimberidou

1 joint publications

David J Vining

1 joint publications

Sukeshi P Arora

1 joint publications

Sofia de Achaval

1 joint publications

John Kauh

1 joint publications

Carrie Cartwright

1 joint publications

Rony Avritscher

1 joint publications

Imran Alibhai

1 joint publications

David J Tweardy

1 joint publications

Ahmed O Kaseb

Frequent Collaborators

1 joint publications

Apostolia M Tsimberidou

1 joint publications

David J Vining

1 joint publications

Sukeshi P Arora

1 joint publications

Sofia de Achaval

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.2K
See more related videos

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.2K
See more related videos